Abstract

Tacrolimus (FK506), a novel immunosuppressant, has been used in liver transplantation and atopic dermatitis since it was discovered in 1984. In the field of eye diseases, eyedrops of tacrolimus has shown efficacy in immune-based inflammatory disorders (such as immune conjunctival and corneal diseases including vernal keratoconjunctivitis, refractory allergic conjunctivitis and autoimmune conjunctivitis). As research developed, eyedrops of tacrolimus has been widely applied in graft-versus-host disease, corneal graft rejection, and oral or intravitreal injection of tacrolimus applied in refractory uveitis. (Int Rev Ophthalmol, 2018, 42: 318-322) Key words: tacrolimus; immunosuppressant; vernal keratoconjunctivitis; graft versus host disease

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.